Focusing marketing spend on Key Opinion Leaders (KOL) is nothing new for pharma, but what can be done to optimise spending? We discuss how to better identify the new breed of KOLs in pharma and develop a valuable relationship, which can help towards brand amplification.
Given the current need for cost containment in the pharmaceutical industry, brand teams are increasingly being asked to achieve more with less resource, leaving little room for experimentation with new channels. Find out how you can experiment with social media with minimal investment, using a pilot approach.
The things your friends like on Google+ have as much weight in search engine results as traditional SEO tactics of the website you are searching for. But how do you optimise for Social Search if you are a website?